Case Law, EPO, Exceptions to patentability, France, FRAND, Injunction, Inventive step, IP Management, Litigation, Novelty, Patents, SEP

(Dhenne Avocats)/

In the first part of this interview (see here), I already mentioned some of the preconceived ideas about French Courts, which makes France almost systematically considered as one of the last territory to litigate: jurisdictions would be anti-patentee, slow, unable to order preliminary injunctions, even not “specialized”. The Cross-Examination Part I of Mrs. Nathalie Sabotier…

Case Law, EPC, EPO Decision, Patents

(Dhenne Avocats)/ /9 Comments

G 1/19, which admits the patentability of a computer-implemented simulation, was the second opportunity for the Enlarged Board of Appeal to rule on the assessment of the patentability of computer-implemented inventions. Did it take advantage of this One More Chance or was it only One More Time? At any rate, here, I will only briefly comment…

(Compulsory) license, France, Patents, Pharmaceutical patent

(Dhenne Avocats)/ /6 Comments

Regular readers of the Blog may be aware of my particular interest in pharma patents and, more especially since the Covid-19 pandemic, for compulsory licensing (see for instance here). I was therefore very happy (and pride) to participate in a Collective Tribune bringing together renowned specialists in property and patent laws (academics and practitioners), who…

Case Law, evidence, France, IP Management, Litigation, Patents, Procedure

(Dhenne Avocats)/

It’s an understatement to say that it’s not always very easy to be a French patent litigator in a transnational litigation, in any case a good dose of humor is needed: how many jokes have I heard about our jurisdictional system? Then you have to accept that France is almost systematically considered as the territory…

Case Law, evidence, France, Infringement, Injunction, IP Management, Litigation, Patents, Procedure

(Dhenne Avocats)/

It’s an understatement to say that it’s not easy to be a French patent litigator in transnational litigation, in any case a good dose of humor is needed: how many jokes have I heard about our jurisdictional system? Then you have to accept that France is almost systematically considered as the territory at the bottom…

(Cross-border) jurisdiction, FRAND, Litigation, SEP

(Dhenne Avocats)/

For the second time, I will have the pleasure and the Honor of welcoming Professor Anne-Catherine Chriariny. Professor Chiariny teaches Patent Law and International Private Law at the University of Montpellier. She is notably the author of a famous doctoral thesis on international patent litigation awarded by the Prix Pierre Véron and published in 2006…

France, Infringement, Litigation, Patents, Pharma, Pharmaceutical patent

(Dhenne Avocats)/

Readers of the Blog should remember the French landmark French judgment rendered in September 2020 in the European Pemetrexed saga, which condemned Fresenius to pay € 28 million in damages (see here). This time the action brought by Eli Lilly on French territory concerns the same drug but is directed against another generic commercialized by Zentiva….

(Cross-border) jurisdiction, Case Law, CJEU, FRAND, Litigation, Procedure, SEP

(Dhenne Avocats)/ /9 Comments

I have the pleasure and the honor of welcoming today Professor Anne-Catherine Chriariny. Professor Chiariny teaches Patent Law and International Private Law at the University of Montpellier. She is notably the author of a famous doctoral thesis on international patent litigation awarded by the Prix Pierre Véron and the Prix Cercle Montesquieu in 2007, published in…

EPO, European Union, France, Germany, Legislation, Patents, Unitary Patent, United Kingdom, UPC

(Dhenne Avocats)/ /23 Comments

After BREXIT, ratification and then withdrawal by the UK, a referral to the German Constitutional Court (“Bundesverfassungsgericht“) and finally a ratification by its parliament, the UPC project is once again blocked in Germany, as previously before the Bundesverfassungsgericht. Like the phoenix, the project is constantly reborn. But should we resist, or should we surrender? What think of…